Clinical Trial Update: Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA) [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab plus carboplatin in metastatic breast cancer (PEMBRACA) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: CORTESI LAURA | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED